Pharmaceutical Substances Syntheses, Patents, Applications - Part 198

Pharmaceutical Substances Syntheses, Patents, Applications - Part 198. Reference containing a collection of 2267 active pharmaceutical ingredients, including those launched recently. Listed alphabetically according to their INNs and established a link between INNs, structure, synthesis and production processes, patent and literature situation, medical use, and trade names. For pharmacists and researchers. | Tandospirone T 1971 I Omnic Yamanouchi USA Flomax Boehringer J Harnal Yamanouchi Ingelheim 1997 Tandospirone ATC N05BX SM-3997 as citrate Use anx olytic antidepressant RN 87760-53-0 MF C21H2S N5O2 MW CN 3aa 4ß 7ß 7aa -hexahydro-2- 4- 4- 2-pyrimidinyl -l-piperazinyl butyl -4 7-methano lH-isoindole- 1 3 2Z7 -dione citrate RN 112457-95-1 MF C2IH29N5O2 . C6H8O7 MW 1- pyrimidin-2-yl -piperazine 1. NaOH H2O hAu 2. LiAIH4 -------2-------------------Ï 4- 4- pyrímidỉn-2-yl -piperazin-1 -yljbutylamine I C 2. Hj cat. ---L----- nortorn-5-ene- ocid anhydride norbarnane-2exo 3exo-dicarboxylic acid anhydride n pyridine A II -------------- I Reference s EP 82 402 Sumitomo Chem. appl. J-prior. . IP60 087 262 Sumitomo Chem. appl. USA-prior. . JP 63 010 760 Sumitomo Chem. appl. J-prior. . use ớ tandospirone a treating depression US 5 011 841 Pfizer appl. USA-prior. . b as psychotropic agents US 5 521 313 Bristol-Myers Squibb appl. USA-prior. . c as 5-HTịA-receptor agonist WO 9 605 817 Medinova SF appl. GB-prior. . 1972 T Tazanolast dosage forms US 5 330 762 Alza Corp. appl. USA-prior. . US 5 246 711 Alza Corp. appl. USA-prior. . US 5 246 710 Alza Corp. appl. USA-prior. . US 5 185 158 Alza Corp. appl. USA-prior. . synergistic compositions with 8-hydroxy-2- dipropylamino tetraline and idazoxan US 5 124 346 Pfizer appl. USA-prior. . synthesis ofl Kikuo I. et al. Chem. Pharm. Bull. CPBTAL 39 2288 1991 . Wu et al. J. Med. Chem. JMCMAR 15 477 1972 . Formulation s tabl. 5 mg 10 mg Trade Name s J Sediel Sumitomo Tazanolast ATC R03DX Use antiallergic antiasthmatic RN 82989-25-1 MF C13H15N5O3 MW LD50 1121 mg kg M . 4 g kg M . 1119 mg kg R . 4 g kg R . 4 g kg dog . CN oxo 3- .

Không thể tạo bản xem trước, hãy bấm tải xuống
TÀI LIỆU MỚI ĐĂNG
Đã phát hiện trình chặn quảng cáo AdBlock
Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.